Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

Study Title
Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
Teva Identifier
TNC GA MS 2004_01
ClinicalTrials.gov Identifier
NCT00203047
Study Status
Terminated
Trial Condition(s)
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: Glatiramer Acetate | Drug: Placebo | Drug: Prednisone

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 55 Years
Trial Duration
01/01/2005 - 05/01/2009
Phase
Phase 4

Study Type

Interventional